Effect of a hypoxic cell sensitizer doranidazole on the radiation-induced apoptosis of mouse L5178Y lymphoma cells

Journal of Radiation Research

Volumn 43, Issue 2, 2002, Pages 161-166

  Aoki, Mizuho ^a   Furusawa, Yoshiya ^a   Shibamoto, Yuta ^b   Kobayashi, Ataru ^c   Tsujitani, Michihiko ^c  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c POLA CHEMICAL INDUSTRIES INC   (Japan)

Author keywords

Apoptosis; Doranidazole; Hypoxic cell sensitizer; L5178Y Cells; Radiosensitizer

Indexed keywords

CHROMOSOMES; CONDENSATION; DNA; IRRADIATION; LADDERS;

AEROBIC CONDITION; CHROMATIN CONDENSATION; DNA LADDER; DORANIDAZOLE; HYPOXIC CELL SENSITIZER; HYPOXIC CELLS; L5178Y CELL; RADIATION-INDUCED APOPTOSIS; RADIOSENSITIZERS; SENSITISER;

CELL DEATH;

DORANIDAZOLE; IMIDAZOLE DERIVATIVE; RADIOSENSITIZING AGENT;

ANIMAL; APOPTOSIS; ARTICLE; CELL CULTURE; DRUG EFFECT; LYMPHOMA; MOUSE; PATHOPHYSIOLOGY;

ANIMALS; APOPTOSIS; IMIDAZOLES; LYMPHOMA; MICE; RADIATION-SENSITIZING AGENTS; TUMOR CELLS, CULTURED;

EID: 0036616247     PISSN: 04493060     EISSN: None     Source Type: Journal    
DOI: 10.1269/jrr.43.161     Document Type: Article

References (19)

1. Adams, G. E. (1978) Hypoxic cell sensitizers for radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 4: 135-141.
2. Shihamoto, Y., Nishimoto, S., Mi, F., Sasai, K., Kagiya, T. and Abe, M. (1987) Evaluation of various types of new hypoxic cell sensitizers using the EMT6 single cell-spheroid-solid tumor system. Int. J. Radiat. Biol. 52: 347-357
3. Kapoor, S., Mathew, R., Huilgol, N. G., Kagiya, V. T. and Nair, C. K. K. (2000) Redox reactions of sanazole (AK-2123) in aqueous solutions: a pulse radiolysis study. J. Radiat. Res. 41: 355-366.
4. Overgaard, J., Sand Hansen, H. and Overgaard, M. (1989) Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study. Int. J. Radiat. Oncol. Biol. Phys. 16: 1065-1068.
5. Dische, S., Chassagne, D., Hope-Stone, H. F., Dawes, P. J. D. K., Roberts, J. T., Yosef, H., Bey, P., Horiot, J. C., Jacobson, A., Frankendal, B., Gonzales Gonzales, D., Nguyen, T. D., Daly, N. J., Le Floch, O., Newman, H., Vieiro, E., Bennett, M. H., Bichel, P., Duvillard, P., Cook, P. A., Everett, V. and Machin, D. (1993) A trial of Ro 03-8799 (pimonidazole) in carcinoma of the uterine cervix: an interim report from the Medical Research Council Working Party on advanced carcinoma of the cervix. Radiother. Oncol. 26: 93-103.
6. Lee, D. J., Cosmatos, D., Marcial, V. A., Fu, K. K., Rotman, M., Cooper, J. S., Ortiz, H. G., Beitler, J. J., Abrams, R. A., Curran, W. J., Coleman, C. N. and Wasserman, T. H. (1995) Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas. Int. J. Radiat. Oncol. Biol. Phys. 32: 67-576.
7. Shibamoto, Y., Ohshio, G., Hosotani, R., Nishimura, Y., Manabe, T., Imamura, M. and Abe, M. (1997) A phase I/II study of a hypoxic cell radiosensitizer KU-2285 in combination with intraoperative radiotherapy. Br. J. Cancer 76: 1474-1479.
8. Overgaard, J., Sand Hansen, H., Overgaard, M., Bastholt, L., Berthelsen, A., Specht, L., Lindelov, B. and Jorgensen, K. (1998) A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiother. Oncol. 46: 135-146.
9. Overgaard, J. (1994) Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors. Oncol. Res. 6: 509-518.
10. Murayama, C., Suzuki, A., Sato, C., Tanabe, Y., Shoji, T., Miyata, Y., Nishio, A., Suzuki, T., Sakaguchi, M. and Mori, T. (1993) Radiosensitization by a new potent nucleoside analog: 1-(1′,3′,4′-trihydroxy-2′-butoxy)methyl-2-nitroimidazole (RP-343). Int. J. Radiat. Oncol. Biol. Phys. 26: 433-443.
11. Oya, N., Shibamoto, Y., Sasai, K., Shibata, T., Murata, R., Takagi, T., Iwai, H., Suzuki, T. and Abe, M. (1995) Optical isomers of a new 2-nitroimidazole nucleoside analog (PR-350 series): radiosensitization efficiency and toxicity. Int. J. Radial. Oncol. Biol. Phys. 33: 119-127.
12. Matsuoka, H., Shibamoto, Y., Kubota, T., Tsujitani, M. and Majima T. (2000) In vivo efficacy and pharmacokinetics of a new hypoxic cell radiosensitizer doranidazole in SUIT-2 human pancreatic cancer xenografted in mouse pancreas. Oncol. Rep. 7: 23-26.
13. Shibamoto, Y., Kubota, T., Kishii, K. and Tsujitani, M. (2000) Radiosensitivity of human pancreatic cancer cells in vitro and in vivo, and the effect of a new hypoxic cell sensitizer, doranidazole. Radiother Oncol 56: 265-270.
14. Nemoto, K., Shibamoto, Y., Ohmagari, J., Baba, Y., Ebe, E., Ariga, H., Takai, Y., Ouchi, A., Sasai, K., Shinozaki, M., Tsujitani, M., Sakaguchi, M., Yamada, S. and Sakamoto, K. (2001) A phase Ia study of a hypoxic cell sensitizer doranidazole (PR-350) in combination with conventional radiotherapy. Anti-Cancer Drugs 12: 1-6.
15. 20Ne-Ion Beams. Radiat. Res. 154: 485-496.
16. Aoki, M., Furusawa, Y. and Yamada, T. (2000) LET dependency of heavy-ion induced apoptosis in V79 cells. J. Radiat. Res. 41: 163-175.
17. Choi, K. H., Hama-Inaba, H., Wang, B., Haginoya, K., Odaka, T., Yamada, T., Hayata, I. and Ohyama, H. (2000) UVC-induced apoptosis in human epithelial tumor A431 cells: sequence of apoptotic changes and involvement of caspase (-8 and -3) cascade. J. Radiat. Res. 41: 243-258.
18. Hasegawa, M., Yagi, K., Iwakawa, S. and Hirai, M. (2001) Chitosan induces apoptosis via caspase-3 activation in bladder tumor cells. Jpn. J. Cancer Res. 92: 459-466.
19. Ayene, I. S., Bernhard, E. J., McKenna, W. G., Muschel, R. J., Krisch, R. E. and Koch, C. J. (2000) DNA as an important target in radiation-induced apoptosis of MYC and MYC plus RAS transfected rat embryo fibroblasts. Int. J. Radiat. Biol. 76: 343-354.